VRDN logo

VRDN P/OCF Ratio

Current (TTM)-7.45×
VRDN Quarterly P/OCF Ratio (-1046.36× → -18.82×)
High-resolution chart · PNG

VRDN p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Viridian Therapeutics Ors Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-18.8165×
-16.7087×
-111.1005×
-20.8591×
-15.1338×
-11.8347×
-20.9267×
-22.3179×
-18.3143×
-23.3193×
-28.4755×
-17.1783×
-22.7584×
-17.3405×
-34.787×
-33.4841×
-17.7601×
-22.9575×
-13.3716×
-15.4909×
-10.1341×
-9.1759×
-6.8563×
-8.4895×
-8.6781×
-2.3977×
-1.9911×
-2.4529×
-9.588×
-7.5064×
-11.4303×
-24.391×
-43.0963×
-25.2203×
-32.1083×
-34.8558×
-39.1109×
-17.5666×
-30.843×
-71.983×
-34.0825×
-36.9782×
-92.1064×
-48.984×
-116.9988×
-168.4641×
-221.4358×
-329.9656×
-913.2358×
6,054.1446×
-1,076.0635×
-1,299.0323×
-2,628.4514×
-1,046.3623×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.